Paras Pharmaceuticals Ltd

Paras Pharmaceuticals Ltd specializes in health and consumer goods, focusing on the development and marketing of pharmaceutical products and personal care items. The company is committed to enhancing wellness and hygiene across various consumer segments. Paras Pharmaceuticals Ltd is a pharmaceutical company that develops and markets healthcare and consumer products. Founded in 1965, the firm is headquartered in Ahmedabad, India.

In December 2010, the Reckitt Benckiser Group PLC acquired Actis' equity stake in Paras Pharmaceuticals Limited for approximately USD 457. 4 mn, representing a significant investment in the company. The firm has been involved in three total deals. Paras Pharmaceuticals Ltd offers a diverse range of products in the health and personal care sectors, focusing on pharmaceutical formulations and consumer health products.

The company's portfolio is designed to address various consumer needs, ensuring quality and efficacy in its offerings. The products are distributed internationally, reaching various markets across North America, Europe, Asia, and Latin America, emphasizing their global presence. Paras Pharmaceuticals Ltd generates revenue through the sales of its pharmaceutical and personal care products, with transactions occurring through direct-to-consumer sales and partnerships with retailers. The company's pricing reflects a premium positioning, with bulk sales to retailers and direct purchases available through e-commerce and physical stores, ensuring broad access to its products.

The company plans to leverage its recent funding from the Trade Sale in December 2010 to enhance product development initiatives and expand its market reach. Specific upcoming products are under design, aiming for release within the next few years. Furthermore, Paras Pharmaceuticals Ltd is targeting expansion into additional regions, focusing on increasing its foothold in emerging markets by 2025.